Showing 531-540 of 2393 results for "".
Rehabilitation for People with Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/rehabilitation-for-people-with-movement-disorders/32043/There are 2 main objectives to neurologic rehabilitation for people with movement disorders: 1) to maintain body structure and 2) to maximize functional skills.Molecular Imaging Biomarkers in Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/molecular-imaging-biomarkers-in-dementia/31729/Amyloid and tau PET imaging aids evaluation of patients suspected of having Alzheimer disease or other dementias.Brain Imaging in Differential Diagnosis of Dementia
https://practicalneurology.com/diseases-diagnoses/imaging-testing/brain-imaging-in-differential-diagnosis-of-dementia/31533/Imaging biomarkers hold the promise of earlier diagnosis that may lead to more effective treatment.Neuromuscular Amyloidosis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-amyloidosis/31815/The most common amyloidosis are both treatable; accurate diagnosis is paramount.The Immune Stroke Spectrum: Navigating Inflammatory Cerebrovascular Disorders
https://practicalneurology.com/diseases-diagnoses/stroke/the-immune-stroke-spectrum-navigating-inflammatory-cerebrovascular-disorders/49163/This review provides a concise overview of commonly encountered inflammatory cerebrovascular disorders, highlighting their clinical features, diagnostic challenges, and treatment strategies, and emphasizing that despite their complexity, early recognition and systematic management often lead to fFriedreich Ataxia: Pathophysiology and Treatment
https://practicalneurology.com/diseases-diagnoses/movement-disorders/friedreich-ataxia-pathophysiology-and-treatment/32041/Great strides have been made in understanding the pathophysiology of Friedreich ataxia, and a variety of treatments are available, including the first drug approved for Friedreich ataxia treatment in 2023.Neuroimaging Biomarkers in Alzheimer Disease and Related Dementias: From Structural MRI to Amyloid and Tau PET
https://practicalneurology.com/diseases-diagnoses/imaging-testing/neuroimaging-biomarkers-in-alzheimer-disease-and-related-dementias-from-structural-mri-to-amyloid-and-tau-pet/56376/This practical guide explains how multimodal neuroimaging refines the diagnosis of Alzheimer disease, frontemporal dementia, dementia with Lewy bodies, and vascular dementia.- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31019/Optimizing Restless Legs Syndrome Treatment: Insights from Recent Meta-Analysis and Clinical ExperiencesA recent meta-analysis evaluating the side effects and wearing-off effects of four Restless Legs Syndrome (RLS) medications highlighted significant findings relevant to clinical practice. The stud
- Second Opinionshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0505SecondOpinion-pdf/31458/Addressing the AD-VaD Diagnostic Challenge in NeurologyIn the debate surrounding Alzheimer’s Disease (AD) versus vascular dementia (VaD) diagnosis, Dr. Geldmacher’s April 2005 article, “Diagnosing Alzheimer’s: Easy Answers vs. Right Answers,” ignited significant discourse. Dr. Geldmacher critiques c
Meningeal Enhancement Seen on Workup for Memory Loss
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/meningeal-enhancement-seen-on-workup-for-memory-loss/30222/Inflammation in the context of memory loss reminds us of the importance of checking opening pressure on lumbar puncture.